Research Progress in Oxygen Carrier Design and Application

Mol Pharm. 2023 Sep 4;20(9):4373-4386. doi: 10.1021/acs.molpharmaceut.3c00289. Epub 2023 Aug 14.

Abstract

Ischemia or hypoxia can lead to pathological changes in the metabolism and function of tissues and then lead to various diseases. Timely and effective blood resuscitation or improvement of hypoxia is very important for the treatment of diseases. However, there is a need to develop stable, nontoxic, and immunologically inert oxygen carriers due to limitations such as blood shortages, different blood types, and the risk of transmitting infections. With the development of various technologies, oxygen carriers based on hemoglobin and perfluorocarbon have been widely studied in recent years. This paper reviews the development and application of hemoglobin and perfluorocarbon oxygen carriers. The design of oxygen carriers was analyzed, and their application as blood substitutes or oxygen carriers in various hypoxic diseases was discussed. Finally, the characteristics and future research of ideal oxygen carriers were prospected to provide reference for follow-up research.

Keywords: blood substitutes; hemoglobin; oxygen carriers; perfluorocarbons; tumor hypoxia.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Substitutes*
  • Fluorocarbons*
  • Hemoglobins
  • Humans
  • Hypoxia
  • Oxygen

Substances

  • Oxygen
  • Blood Substitutes
  • Fluorocarbons
  • Hemoglobins